Post job

Seagen's revenue is $2.0 billion.

What is Seagen's revenue?

Seagen's annual revenue is $2.0B. Zippia's data science team found the following key financial metrics about Seagen after extensive research and analysis.
  • Seagen's revenue growth from 2000 to 2022 is 1,989,530.14%.
  • Seagen has 900 employees, and the revenue per employee ratio is $2,180,457.
  • Seagen's peak quarterly revenue was $1.1B in 2020(q3).
  • Seagen peak revenue was $2.2B in 2020.
  • Seagen annual revenue for 2021 was 1.6B, -27.63% growth from 2020.
  • Seagen annual revenue for 2022 was 2.0B, 24.65% growth from 2021.

On this page

Most recent quarter revenue
$648.7M (Q3'2023)
Company most recent quarter revenue
Peak revenue
$2.2B (2020)
Company peak revenue
Revenue / employee
$2.2M
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$648.7M (Q3'2023)
Company most recent quarter revenue
Peak revenue
$2.2B (2020)
Company peak revenue
Revenue / employee
$2.2M
Company revenue / employee

Seagen historical revenue

Seagen's peak revenue was $2.2B in 2020. The peak quarterly revenue was $1.1B in 2020(q3).

Seagen's revenue increased from $98.6k in 2000 to $2.0B currently. That's a 1,989,530.14% change in annual revenue.

Seagen annual revenue

$2B
$2B
$1B
$870M
$435M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022

Seagen annual revenue over time

Fiscal year / yearSeagen revenue
2009$52.0M
2010$107.5M
2011$94.8M
2012$210.8M
2013$269.3M
2014$286.8M
2015$336.8M
2016$418.1M
2017$482.3M
2018$654.7M
2019$916.7M
2020$2.2B
2021$1.6B
2022$2.0B

How accurately did Seagen's revenue projections match actual performance?

Zippia waving zebra

Seagen annual growth

Seagen saw the greatest revenue growth in 2002, when revenue increased by 514.6%.

Seagen had the lowest revenue growth in 2021, when revenue changed by -27.63%.

Seagen annual growth rate over time

YearSeagen growth
2009
47%
2010
107%
2011
-12%
2012
122%
2013
28%
2014
6%
2015
17%
2016
24%
2017
15%
2018
36%
2019
40%
2020
137%
2021
-28%
2022
25%

Seagen quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$1B
$849M
$637M
$425M
$212M
$0
2019
2020
2021
2022
2023

Seagen quarterly growth rate over time

YearQ1Q2Q3Q4
2009$9.1M$9.4M$11.6M$21.8M
2010$46.5M$36.9M$16.0M$8.1M
2011$12.2M$13.1M$20.7M$48.9M
2012$48.2M$48.8M$49.8M$63.9M
2013$57.3M$73.6M$71.0M$67.4M
2014$68.3M$68.3M$75.9M$74.3M
2015$82.2M$77.1M$84.1M$93.5M
2016$111.2M$95.4M$106.3M$105.3M
2017$109.1M$108.2M$135.3M$129.6M
2018$140.6M$170.2M$169.4M$174.5M
2019$195.2M$218.4M$213.3M$289.8M
2020$234.5M$278.0M$1.1B$601.3M
2021$332.0M$388.5M$424.1M$429.9M
2022$426.5M$497.5M$510.3M$528.2M
2023$519.7M$603.8M$648.7M-

Seagen jobs nearby

Do you work at Seagen?

Is Seagen transparent about its revenue structure?

Seagen financial information

CEORoger D. Dansey
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number900
Date Founded1997
HeadquartersBothell, Washington
Number of Locations3
Revenue$2.0B
Net Income-$610,308,000
Gross Proft$1.6B (2022)
Tax Rate-0.0%
Total Assets$3,674,532,000
TickerSGEN

Seagen jobs you might like

Seagen financing

Seagen received early financing of $155.0M on 2011-02-02.

SeriesRound sizeDate
Post-IPO Equity - Seattle Genetics$575M07/2019
Post-IPO Equity - Seattle Genetics$9M01/2014
Post-IPO Equity - Seattle Genetics$155M02/2011

Seagen investors

InvestorsSecurity type
Takeda PharmaceuticalPost-IPO Equity - Seattle Genetics

Seagen competitors

Seagen's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.

Seagen's smallest competitor is Morphotek with revenue of $4.8M last year.

Seagen revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Seagen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Seagen. The employee data is based on information from people who have self-reported their past or current employments at Seagen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Seagen. The data presented on this page does not represent the view of Seagen and its employees or that of Zippia.

Seagen may also be known as or be related to Seagen, Seagen Inc, Seattle Genetics, Seattle Genetics Inc and Seattle Genetics, Inc.